A primary lesion of advanced melanoma in pregnancy: case report and review of literature of the advanced cases in the last ten years

References

• Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol. 2014;211(1):7–14.
   PubMed Web of Science ®Google Scholar
• Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011;20(4):e175–e185.
   PubMed Web of Science ®Google Scholar
• Han SN, Lotgerink A, Gziri MM, et al. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med. 2012;10:86.
   PubMed Web of Science ®Google Scholar
• Cottreau CM, Dashevsky I, Andrade SE, et al. Pregnancy-associated cancer: a U.S. population-based study. J Womens Health (Larchmt)). 2019;28(2):250–257.
   PubMed Web of Science ®Google Scholar
• Dillman RO, Vandermolen LA, Barth NM, et al. Malignant melanoma and pregnancy ten questions. West J Med. 1996;164(2):156–161.
   PubMedGoogle Scholar
• Mendizábal E, De León-Luis J, Gómez-Hidalgo NR, et al. Maternal and perinatal outcomes in pregnancy-associated melanoma. Report of two cases and a systematic literature review. Eur J Obstet Gynecol Reprod Biol. 2017;214:131–139.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Ishida I, Yamaguchi Y, Tanemura A, et al. Stage III melanoma treated with chemotherapy after surgery during the second trimester of pregnancy. Arch Dermatol. 2009;145(3):346–348.
   PubMedGoogle Scholar
• Mathew M, Sheik S, Rao K, et al. Metastatic malignant melanoma during pregnancy: case report and a review of the literature. Sultan Qaboos Univ Med J. 2009;9(1):79–83.
   PubMedGoogle Scholar
• Mestnik NC, Afonso JP, Enokihara MM, et al. Melanoma developed during pregnancy-a case report. An Bras Dermatol. 2014;89(1):157–159.
   PubMed Web of Science ®Google Scholar
• Maleka A, Enblad G, Sjörs G, et al. Treatment of metastatic malignant melanoma with vemurafenib during pregnancy. J Clin Oncol. 2013;31(11):e192–e193.
   PubMed Web of Science ®Google Scholar
• Gottschalk N, Jacobs VR, Hein R, et al. Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge. Onkologie. 2009;32(12):748–751.
   PubMedGoogle Scholar
• Valenzano Menada M, Moioli M, Garaventa A, et al. Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature. Melanoma Res. 2010;20(6):443–449.
   PubMed Web of Science ®Google Scholar
• De Carolis S, Garofalo S, Degennaro VA, et al. Placental and infant metastasis of maternal melanoma: a new case. J Obstet Gynaecol. 2015;35(4):417–418.
   PubMedGoogle Scholar
• Jasaitiene D, Valiukeviciene S, Makstiene J, et al. Metastatic amelanotic nodular melanoma during pregnancy. Medicina (Kaunas)). 2008;44(6):467–471.
   PubMed Web of Science ®Google Scholar
• Ustaalioglu BBO, Gumus M, Unal A, et al. Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences. Int J Gynecol Cancer. 2010;20(5):698–703.
   PubMed Web of Science ®Google Scholar
• Sioulas VD, Panayiotides IG, Chrelias C, et al. Ovarian melanoma complicating pregnancy achieved by in-vitro fertilisation. J Obstet Gynaecol. 2013;33(1):89–91.
   PubMedGoogle Scholar
• Pagès C, Robert C, Thomas L, et al. Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol. 2010;162(2):274–281.
   PubMed Web of Science ®Google Scholar
• Wielowieyska-Szybińska DK, Spałkowska M, Wojas-Pelc A. Melanoma in pregnancy: a case report and review of the literature. Postepy Dermatol Alergol. 2015;32(6):483–487.
   PubMed Web of Science ®Google Scholar
• Katz VL, Farmer RM, Dotters D. Focus on primary care: from nevus to neoplasm: myths of melanoma in pregnancy. Obstet Gynecol Surv. 2002;57(2):112–119.
   PubMed Web of Science ®Google Scholar
• Gunduz K, Koltan S, Sahin MT, et al. Analysis of melanocytic naevi by dermoscopy during pregnancy. J Eur Acad Dermatol Venereol. 2003;17(3):349–351.
   PubMed Web of Science ®Google Scholar
• Zampino MR, Corazza M, Costantino D, et al. Are melanocytic nevi influenced by pregnancy? A dermoscopic evaluation. Dermatol Surg. 2006;32(12):1497–1504.
   PubMed Web of Science ®Google Scholar
• Zalaudek I, Wolf IH, Hofmann-Wellenhof R, et al. Dermatoscopic follow-up of a changing pigmented melanocytic skin lesion during pregnancy: from nevus to melanoma? Melanoma Res. 2004;14(4):323–325.
   PubMed Web of Science ®Google Scholar
• Fernö M, Borg A, Erichsen C, et al. Estrogen and progesterone receptors in melanoma metastases with special reference to analytical methods and prognosis. Anticancer Res. 1984;4(3):179–182.
   PubMed Web of Science ®Google Scholar
• Tanemura A, van Hoesel AQ, Mori T, et al. The role of estrogen receptor in melanoma. Expert Opin Ther Targets. 2007;11(12):1639–1648.
   PubMed Web of Science ®Google Scholar
• Li J, Fang X, Chen X, et al. Selective expression of progesterone receptor in malignant melanoma was inversely correlated with PCNA. J Huazhong Univ Sci Technol Med Sci. 2008;28(2):216–218.
   PubMedGoogle Scholar
• Morvillo V, Lüthy IA, Bravo AI, et al. Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases. Melanoma Res. 2002;12(6):529–538.
   PubMed Web of Science ®Google Scholar
• Kanda N, Watanabe S. 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol. 2001;117(2):274–283.
   PubMed Web of Science ®Google Scholar
• Miller JG, Gee J, Price A, et al. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma. Melanoma Res. 1997;7(3):197–208.
   PubMed Web of Science ®Google Scholar
• Keller G, Schally AV, Gaiser T, et al. Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue. Cancer Res. 2005;65(13):5857–5863.
   PubMed Web of Science ®Google Scholar
• Karagas MR, Zens MS, Stukel TA, et al. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control. 2006;17(1):11–19.
   PubMed Web of Science ®Google Scholar
• Gandini S, Iodice S, Koomen E, et al. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer. 2011;47(17):2607–2617.
   PubMed Web of Science ®Google Scholar
• Kvaskoff M, Bijon A, Mesrine S, et al. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. Am J Epidemiol. 2011;173(10):1192–1202.
   PubMed Web of Science ®Google Scholar
• Ellerhorst JA, Diwan AH, Dang SM, et al. Promotion of melanoma growth by the metabolic hormone leptin. Oncol Rep. 2010;23(4):901–907.
   PubMed Web of Science ®Google Scholar
• Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod. 2006;74(2):218–229.
   PubMed Web of Science ®Google Scholar
• Driscoll MS, Grant-Kels JM. Melanoma and pregnancy. G Ital Dermatol Venereol. 2008;143(4):251–257.
   PubMedGoogle Scholar
• Pagani E, Ruffini F, Antonini Cappellini GC, et al. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness. Int J Oncol. 2016;48(4):1581–1589.
   PubMed Web of Science ®Google Scholar
• Alexander A, Samlowski WE, Grossman D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21(11):2179–2186.
   PubMed Web of Science ®Google Scholar
• Sosman JA. Immunotherapy of advanced melanoma with immune checkpoint inhibition. UpToDate; 2015. Available from: https://www.uptodate.com/contents/immunotherapy-of-advanced-melanoma-with-immune-checkpoint-inhibition.
   Google Scholar
• John L, Cowey CL. The rapid emergence of novel therapeutics in advanced malignant melanoma. Dermatol Ther (Heidelb)). 2015;5(3):151–169.
   PubMed Web of Science ®Google Scholar
• Maleka A, Enblad G, Sjörs G, et al. Treatment of metastatic malignant melanoma with vemurafenib during pregnancy. J Clin Oncol. 2013;31:2012–2013.
   Web of Science ®Google Scholar
• Grunewald S, Jank A. New systemic agents in dermatology with respect to fertility, pregnancy, and lactation. J Dtsch Dermatol Ges. 2015;13(4):277–290.
   PubMed Web of Science ®Google Scholar
• Wang S-C, Li Y-H, Piao H-L, et al. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. 2015;6:e1738.
   PubMed Web of Science ®Google Scholar